Iván Cavero-Redondo1, Bárbara Peleteiro2,3, Celia Álvarez-Bueno4, Enrique G Artero5, Miriam Garrido-Miguel1, Vicente Martinez-Vizcaíno1,6. 1. Universidad de Castilla-La Mancha, Health and Social Research Center, Cuenca, Spain. 2. EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal. 3. Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina, Universidade do Porto, Porto, Portugal. 4. Universidad de Castilla-La Mancha, Health and Social Research Center, Cuenca, Spain. celia.alvarezbueno@uclm.es. 5. SPORT Research Group (CTS-1024), University of Almería, Almería, Spain. 6. Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca, Chile.
Abstract
BACKGROUND: Physical activity is widely perceived to be beneficial for preventing type 2 diabetes mellitus and for controlling glycaemic levels in patients with type 2 diabetes, but evidence supporting a positive effect in the control of glycaemic levels in healthy people is rather weak. The aim of this review was to estimate the effect of physical activity on glycaemic control measured by glycosylated haemoglobin (HbA1c) levels in non-diabetic populations, and to determine which type of physical activity has a greater influence on glycaemic control. METHODS: We systematically searched the MEDLINE, EMBASE, Cochrane Library and Web of Science databases, from inception to May 2017, for experimental studies addressing the effect of physical activity on glycaemic control measured by HbA1c levels in non-diabetic populations. The DerSimonian and Laird method was used to compute pooled estimates of effect size (ES) and respective 95% confidence intervals (CIs). The effect of physical activity on HbA1c levels was estimated in two ways: (1) physical activity intervention versus control; and (2) physical activity pre-post intervention. Additionally, subgroup analyses were performed based on age of participants and different aspects of the intervention. RESULTS: Fifteen published studies were included in the meta-analysis. In analyses comparing physical activity intervention and control, we found a decrease of HbA1c levels in favour of the intervention group (ES = 0.32; 95% CI 0.01-0.62) with substantial heterogeneity (I2 = 63.2%; p = 0.008). In the pre-post analysis, there was a decrease in HbA1c levels post physical activity intervention (ES = 0.17; 95% CI 0.01-0.33) with low heterogeneity (I2 = 25.8%; p = 0.164). Additionally, for physical activity intervention versus control, a decrease in HbA1c levels was observed in resistance exercise and in intervention length below 12 weeks. Furthermore, for pre-post effect analyses, a decrease in HbA1c levels was observed in the supervised physical activity programme, other type of exercises, intervention length below 12 weeks and exercise intervention week duration above 150 min subgroups. CONCLUSIONS: This systematic review and meta-analysis provides an overview of the evidence supporting physical activity as a suitable intervention for glycaemic control as measured by HbA1c levels in non-diabetic populations. TRIAL REGISTRATION: PROSPERO CRD42016050991.
BACKGROUND: Physical activity is widely perceived to be beneficial for preventing type 2 diabetes mellitus and for controlling glycaemic levels in patients with type 2 diabetes, but evidence supporting a positive effect in the control of glycaemic levels in healthy people is rather weak. The aim of this review was to estimate the effect of physical activity on glycaemic control measured by glycosylated haemoglobin (HbA1c) levels in non-diabetic populations, and to determine which type of physical activity has a greater influence on glycaemic control. METHODS: We systematically searched the MEDLINE, EMBASE, Cochrane Library and Web of Science databases, from inception to May 2017, for experimental studies addressing the effect of physical activity on glycaemic control measured by HbA1c levels in non-diabetic populations. The DerSimonian and Laird method was used to compute pooled estimates of effect size (ES) and respective 95% confidence intervals (CIs). The effect of physical activity on HbA1c levels was estimated in two ways: (1) physical activity intervention versus control; and (2) physical activity pre-post intervention. Additionally, subgroup analyses were performed based on age of participants and different aspects of the intervention. RESULTS: Fifteen published studies were included in the meta-analysis. In analyses comparing physical activity intervention and control, we found a decrease of HbA1c levels in favour of the intervention group (ES = 0.32; 95% CI 0.01-0.62) with substantial heterogeneity (I2 = 63.2%; p = 0.008). In the pre-post analysis, there was a decrease in HbA1c levels post physical activity intervention (ES = 0.17; 95% CI 0.01-0.33) with low heterogeneity (I2 = 25.8%; p = 0.164). Additionally, for physical activity intervention versus control, a decrease in HbA1c levels was observed in resistance exercise and in intervention length below 12 weeks. Furthermore, for pre-post effect analyses, a decrease in HbA1c levels was observed in the supervised physical activity programme, other type of exercises, intervention length below 12 weeks and exercise intervention week duration above 150 min subgroups. CONCLUSIONS: This systematic review and meta-analysis provides an overview of the evidence supporting physical activity as a suitable intervention for glycaemic control as measured by HbA1c levels in non-diabetic populations. TRIAL REGISTRATION: PROSPERO CRD42016050991.
Authors: Bess H Marcus; David M Williams; Patricia M Dubbert; James F Sallis; Abby C King; Antronette K Yancey; Barry A Franklin; David Buchner; Stephen R Daniels; Randal P Claytor Journal: Circulation Date: 2006-12-04 Impact factor: 29.690
Authors: Harmon Eyre; Richard Kahn; Rose Marie Robertson; Nathaniel G Clark; Colleen Doyle; Yuling Hong; Ted Gansler; Thomas Glynn; Robert A Smith; Kathryn Taubert; Michael J Thun Journal: Circulation Date: 2004-06-15 Impact factor: 29.690
Authors: Marian E Papp; Petra Lindfors; Malin Nygren-Bonnier; Lennart Gullstrand; Per E Wändell Journal: J Altern Complement Med Date: 2015-11-13 Impact factor: 2.579
Authors: Alejandro Carretero-Ruiz; María Del Carmen Olvera-Porcel; Iván Cavero-Redondo; Celia Álvarez-Bueno; Vicente Martínez-Vizcaíno; Manuel Ferrer-Márquez; Alberto Soriano-Maldonado; Enrique G Arter Journal: Obes Surg Date: 2019-10 Impact factor: 4.129
Authors: Hansjoerg Baurecht; Sebastian Edgar Baumeister; Christa Meisinger; Jakob Linseisen; Michael Leitzmann Journal: BMJ Open Diabetes Res Care Date: 2020-12
Authors: M Mähs; J S Pithan; I Bergmann; L Gabrys; J Graf; A Hölzemann; K Van Laerhoven; S Otto-Hagemann; M L Popescu; L Schwermann; B Wenz; I Pahmeier; A Teti Journal: Trials Date: 2022-07-30 Impact factor: 2.728
Authors: Adrian Aguilera; Caroline A Figueroa; Rosa Hernandez-Ramos; Urmimala Sarkar; Anupama Cemballi; Laura Gomez-Pathak; Jose Miramontes; Elad Yom-Tov; Bibhas Chakraborty; Xiaoxi Yan; Jing Xu; Arghavan Modiri; Jai Aggarwal; Joseph Jay Williams; Courtney R Lyles Journal: BMJ Open Date: 2020-08-20 Impact factor: 2.692